Acadia Healthcare Sees FY24 Adj. ESP $3.40-$3.70 Vs $3.70 Est.; Revenue $3.18B-$3.25B Vs $3.215B Est.
Portfolio Pulse from Benzinga Newsdesk
Acadia Healthcare provided its fiscal year 2024 adjusted earnings per share (EPS) guidance in the range of $3.40 to $3.70, compared to the estimated $3.70. The company also forecasts revenue between $3.18 billion and $3.25 billion, versus the estimated $3.215 billion.
February 27, 2024 | 9:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Acadia Healthcare projects its FY24 adjusted EPS to be $3.40-$3.70, slightly below the consensus estimate of $3.70. Revenue is expected to be in the range of $3.18 billion to $3.25 billion, closely aligning with the estimated $3.215 billion.
The guidance provided by Acadia Healthcare for FY24 shows a slight underperformance in EPS compared to the market estimate, which could lead to cautious investor sentiment. However, the revenue forecast is closely aligned with expectations, indicating stability in the company's operational performance. The mixed nature of this guidance suggests a neutral short-term impact on the stock price, as investors may weigh the slight EPS miss against the steady revenue outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100